Key Developments
-
Veerhealth Care Ltd has received a commercial order worth ₹4.8 million for the manufacture and supply of skin and face care products
-
The order follows regulatory approval from the Food and Drug Authority, Gujarat, enabling the company to begin production
Strategic Impact
-
The products will be manufactured under a contract agreement with a leading marketplace company, tailored to their brand specifications
-
This marks a significant step in Veerhealth’s expansion within the personal care segment, reinforcing its position as a trusted contract manufacturer
Operational Outlook
-
The company expects full-capacity operations to meet rising domestic and export demand
-
This order is anticipated to boost revenue and optimize capacity utilization in the coming quarters
Sources: BSE India, Business Upturn, Indian Pharma Post